Myriad Applauds New ACOG Guidelines For Hereditary Breast And Ovarian Cancer
Myriad Genetics, Inc. (NASDAQ: MYGN) announced its support of The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin Number 103, dated April 2009, which sets forth ACOG’s clinical management guidelines for obstetricians and gynecologists.
More: continued here
Filed under: Breast Cancer on March 29th, 2009
You must be logged in to post a comment.